Clinical Trial Update: Anesthesia-Masked Psilocybin Therapy for Major Depression [Phase 2]

View source ↗

Summary

Stanford University's Phase 2 trial of anesthesia-masked psilocybin therapy for major depressive disorder is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin therapy (psilocybin)

Snippet

Sponsor: Stanford University | Conditions: Major Depression | Phase 2 | Status: NOT_YET_RECRUITING